![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2008, European Molecular Biology Organization CENP-V is required for centromere organization, chromosome alignment and cytokinesis 1Wellcome Trust Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, UK 2Department of Biochemistry, PDBEB, Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal 3Image Informatics and Computational Biology Unit, NIH, National Institute on Aging, Baltimore, MD, USA 4Department of Cellular and Molecular Pharmacology, Baskin School of Engineering, University of California, Santa Cruz, CA, USA aWellcome Trust Centre for Cell Biology, The University of Edinburgh, Mayfield Road, Edinburgh, EH9 3JR, UK. Tel.: +44 0131 650 7101; Fax: +44 0132 650 7100; E-mail: bill.earnshaw/at/ed.ac.uk Received December 16, 2007; Accepted July 31, 2008. This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This licence does not permit commercial exploitation without specific permission. This article has been cited by other articles in PMC.Abstract The mechanism of mitotic chromosome condensation is poorly understood, but even less is known about the mechanism of formation of the primary constriction, or centromere. A proteomic analysis of mitotic chromosome scaffolds led to the identification of CENP-V, a novel kinetochore protein related to a bacterial enzyme that detoxifies formaldehyde, a by-product of histone demethylation in eukaryotic cells. Overexpression of CENP-V leads to hypercondensation of pericentromeric heterochromatin, a phenotype that is abolished by mutations in the putative catalytic site. CENP-V depletion in HeLa cells leads to abnormal expansion of the primary constriction of mitotic chromosomes, mislocalization and destabilization of the chromosomal passenger complex (CPC) and alterations in the distribution of H3K9me3 in interphase nucleoplasm. CENP-V-depleted cells suffer defects in chromosome alignment in metaphase, lagging chromosomes in anaphase, failure of cytokinesis and rapid cell death. CENP-V provides a novel link between centromeric chromatin, the primary constriction and the CPC. Keywords: chromosome passenger complex, kinetochore, mitosis, pericentromeric heterochromatin, primary constriction Introduction Chromosome behaviour in mitosis is directed by kinetochores, which regulate the attachment and movement of chromosomes on the mitotic spindle, and ensure the fidelity of chromosome segregation (Rieder and Maiato, 2004; Musacchio and Salmon, 2007). The outer kinetochore is a complex proteinaceous structure, with over 80 components (Maiato et al, 2004; Chan et al, 2005; Cheeseman and Desai, 2008). The inner kinetochore is composed of DNA plus proteins that package it into chromatin. In humans, kinetochores are found on the surface of a domain composed of highly repetitive α-satellite sequences (Hyman and Sorger, 1995; Bjerling and Ekwall, 2002) packaged into condensed heterochromatin. Heterochromatin was first defined (Heitz, 1928) on morphological grounds, but now it is defined in terms of a ‘histone code' of post-translational modifications that influence transitions between chromatin states and the regulation of transcriptional activity (Strahl and Allis, 2000; Jenuwein, 2001; Nightingale et al, 2006; Kouzarides, 2007). For example, histone H4 methylated on lysine 20 (K20) and H3 methylated on lysines 9 or 27 are generally associated with genes the transcription of which is repressed (Bannister et al, 2001; Cao et al, 2002; Peters et al, 2003; Rice et al, 2003; Schotta et al, 2004). Kinetochores also have their own particular chromatin mark, the histone H3 variant CENP-A, which is conserved in eukaryotes from yeast to man (Earnshaw and Rothfield, 1985; Carroll and Straight, 2006; Schueler and Sullivan, 2006). CENP-A-containing chromatin is usually embedded within a large domain of pericentric heterochromatin, which may also be required for proper sister chromatid cohesion and chromosome segregation during mitosis (Nonaka et al, 2002; Dunleavy et al, 2005). Pericentric heterochromatin is rich in H3K9me2/H3K9me3 and hypoacetylated histones H3 and H4 (Dunleavy et al, 2005). Surprisingly, the chromatin domain immediately adjacent to CENP-A has been reported to contain H3K4me2, a mark of ‘open' chromatin (Sullivan and Karpen, 2004). This has led to the suggestion that the inner kinetochore may possess a specialized form of ‘centromere chromatin' rather than euchromatin or heterochromatin (Schueler and Sullivan, 2006). In early mitosis, the heterochromatin beneath the kinetochore is associated with the chromosomal passenger complex (CPC), a widely studied regulator of mitosis with functions ranging from the correction of kinetochore attachment errors to the completion of cytokinesis (Vagnarelli and Earnshaw, 2004; Vader et al, 2006; Ruchaud et al, 2007). To accomplish its diverse functions, the CPC occupies characteristic compartments during mitotic progression—the inner centromeres in early mitosis, and the central spindle and equatorial cortex during mitotic exit (Earnshaw and Cooke, 1991). The mechanism of CPC targeting to these compartments remains a major unanswered question—the checkpoint kinase Bub1 is involved (Boyarchuk et al, 2007), but kinetochore assembly itself does not appear to be required (Oegema et al, 2001). Here, we describe CENP-V, a putative formaldehyde-detoxifying enzyme that is required for normal compaction of heterochromatin and formation of a primary constriction. CENP-V is required for correct localization of the CPC and the centromeric cohesion protector Sgo1. Depletion of CENP-V causes a strong CPC phenotype (difficulties in chromosome bi-orientation and a failure to complete cytokinesis) that is rapidly followed by apoptotic cell death. Results CENP-V is conserved among vertebrates and resembles GFA of Paracoccus denitrificans A proteomic screen for novel human proteins associated with histone-depleted mitotic chromosomes (Gassmann et al, 2005) identified p30, a protein also found in a previous proteomic screen for novel nuclear pore complex components (Cronshaw et al, 2002). p30 was not a nuclear pore component and remained otherwise uncharacterized. As shown below, p30 is a component of the kinetochore of mitotic chromosomes, and for simplicity, we will therefore designate it as CENP-V. The human CENP-V gene located on chromosome 17 encodes a basic protein (pI 9.78) of 275 amino acids (Uniprot Q7Z7K6 PRR6_HUMAN). Sequence similarity searches in publicly available databases using BLAST (Altschul et al, 1990) revealed proteins related to CENP-V in all vertebrates as well as in plants and nematodes (Figure 1A
Only prokaryotic enzymes containing the Gfa domain have been characterized functionally. GFA enzymes (EC no. 4.4.1.22) catalyse the first step of the glutathione-linked oxidation pathway for the conversion of formaldehyde—the condensation of formaldehyde and glutathione to S-hydroxymethylglutathione. In methylotrophic bacteria such as Paracoccus denitrificans and Rhodobacter sphaeroides, GFA is involved in the complete oxidation of methanol to carbon dioxide. In non-methylotrophic bacteria, such as Escherichia coli and in higher organisms, glutathione-linked oxidation serves to detoxify formaldehyde. The crystallographic structure of GFA from P. denitrificans (GFA-Pn) has been solved (Neculai et al, 2005). We used this structure together with multiple alignment information to predict a structure of the conserved region of CENP-V containing the Gfa domain (amino acids 126–260). To produce a three-dimensional (3D) model of this structure, we first generated a target-to-template sequence alignment of CENP-V plus its closest homologues with the GFA subfamily containing the P. denitrificans enzyme sequence. The automated alignment from PFAM required only minor adjustments, and local ambiguities were resolved by considering tertiary structural features in the crystal structure, subfamily-specific conservation in both subfamilies and the predicted secondary structure for the CENP-V subfamily. Using this alignment as input, atomic coordinates were produced with the SYBYL software package (Tripos Inc.), yielding a robust model for the region of CENP-V containing the Gfa domain (Figure 1D The three cysteines present in the catalytic site of GFA-Pn (Figure 1A We predict no notable differences between the surface charge characteristics of CENP-V and the GFA-Pn domains (data not shown). However, a hydrophobic pocket present in the catalytic site of the bacterial protein (Figure 1C CENP-V localizes to kinetochores in early mitosis Affinity-purified rabbit polyclonal antibody Ra4552 raised against full-length CENP-V recognizes a protein of the expected size (30 kDa) on immunoblots of HeLa cell lysates (Figure 2A
Indirect immunofluorescence using this antibody revealed that CENP-V is localized to kinetochores from prometaphase to metaphase (Figure 2B and B′ At anaphase onset, CENP-V transfers to the spindle mid-zone and then the mid-body in telophase and cytokinesis (Figure 2B′′ and B′′′ CENP-V is required for a normal primary constriction of mitotic chromosomes To analyse the role of CENP-V in chromosome structure and function, we depleted the protein by RNAi in HeLa cells. Immunoblotting showed that by 48 h exposure of cells to a specific siRNA, CENP-V was significantly depleted (Figure 3A CENP-V depletion caused a marked change in the structure of mitotic chromosomes in spreads prepared at 48 and 60 h after exposure to specific siRNA. Mitotic chromosomes from CENP-V-depleted cells appeared less compact overall than chromosomes from cells transfected with control siRNA (Figure 3B and C CENP-V depletion also had a remarkable effect on centromere structure in chromosome spreads. In CENP-V-depleted cells, the primary constriction of mitotic chromosomes appeared wider and less focused than that of chromosomes from control cells (Figure 3B and C These changes in chromosomal morphology were not due to changes in the distribution of SMC2. Chromosome arms are slightly decondensed in cells lacking this key condensin subunit (Hudson et al, 2003). However, with the exception of the loss of a focus at the primary constriction, no differences in the distribution of SMC2 were observed in metaphase chromosomes from CENP-V-depleted cells (Figure 4A and A′
CENP-V depletion reduces the centromeric localization of chromosomal passenger proteins and Sgo1 The pronounced effects on the morphology of the primary constriction caused by CENP-V depletion were accompanied by a dramatic change in the distribution of several key centromeric components. In chromosome spreads prepared after 48 h exposure to CENP-V siRNA, INCENP was no longer concentrated in the inner centromere as in control cells, but instead was decreased in intensity and distributed all along the axis between the chromosome arms (Figure 4A′ The apparent depletion of the CPC at inner centromeres was confirmed by quantification of the fluorescence intensity levels for Aurora B. In each case, the level of Aurora B fluorescence was normalized to the level of staining seen for the corresponding centromere using ACA (Figure 4C To determine whether this decline in the levels of centromere-associated CPC proteins was functionally significant, we also stained chromosome spreads for the shugoshin protein Sgo1. The CPC is required for the stable localization of the Drosophila shugoshin MEI-S332 to centromeres in meiosis and mitosis (Resnick et al, 2006), and interactions between these proteins have been observed in a variety of cell types (Dai et al, 2006; Huang et al, 2007; Kawashima et al, 2007). Indeed, depletion of the CPC at centromeres was accompanied by a decrease in Sgo1 after 48 h exposure to CENP-V siRNA (Figure 4B′ Thus, CENP-V is required for the normal structure of the inner centromere in mitotic chromosomes and for the proper centromeric localization of Aurora B, INCENP and Sgo1. CENP-V is required for proper alignment of metaphase chromosomes and for correct cytokinesis If CENP-V is required for CPC function as well as localization during mitosis, we would expect its depletion to produce strong phenotypes. To analyse the consequences of CENP-V depletion, we performed multi-site imaging by DIC and fluorescence microscopy of the chromosomes over 48 h with a 5 min time lapse, starting 24 h after transfection with fluorofore-labelled oligonucleotides. The analysis employed both control and siRNA oligonucleotides in three independent experiments, and more than 60 cells were assessed for each condition. This analysis enabled us to recognize three phenotypes following CENP-V depletion.
Thus, not only does CENP-V depletion produce an apparent perturbation of CPC localization and stability, the subsequent cell death appears to reflect a loss of CPC function during both chromosome bi-orientation and cytokinesis. Mutations in the putative catalytic domain of CENP-V abolish its ability to induce hypercondensation of pericentromeric heterochromatin In cells overexpressing CENP-V–GFP, the transfected protein was found in regions of dense chromatin reminiscent of the chromocentres seen in murine cell lines (Figure 6B
CENP-V overexpression is highly toxic. Most cells transfected with CENP-V traverse mitosis apparently normally, but half of cells die in interphase 17–22 h later (Figure 6D To test whether the chromatin-condensing activity of CENP-V requires its putative catalytic site, we used a site-directed mutagenesis approach to specifically inactivate the putative enzyme function of CENP-V. Mutant CENP-VC174A removes a cysteine involved in binding of the cofactor glutathione in GFA-Pn. Mutant CENP-VCC172/177AA removes the two remaining cysteines of the putative catalytic site (Figure 6A The appearance of the nuclear DNA in HeLa cells transiently transfected and overexpressing CENP-VC174A–GFP or CENP-VCC172/177AA–GFP differed from that of cells overexpressing CENP-V–GFP. Although some regions of condensed chromatin were observed in cells overexpressing the mutant proteins, these were smaller and less abundant than those seen in cells overexpressing wild-type CENP-V (Figure 6B We used a computational pattern recognition approach to provide a quantitative assessment of the differences between wild-type and mutant CENP-V overexpression phenotypes. Deconvolved images of DAPI-stained cells overexpressing CENP-V, the two mutants and untransfected cells were subjected to an analysis of image similarity using WND-CHARM (weighted neighbour distance using a compound hierarchy of algorithms representing morphology) (Orlov et al, 2006). Briefly, in this analysis a four-way classifier was trained to distinguish images of CENP-V–GFP (GFP), mutant A (CENP-VC174A–GFP), mutant B (CENP-VCC172/177AA–GFP), and untransfected cells (NT). The classifier output for each image is a set of marginal probabilities corresponding to its similarity to the four training classes. Relative similarities between images can thus be computed from their respective Euclidian distances in a ‘marginal probability space'. The pairwise similarities between all images were used to construct the dendrogram in Figure 6C This analysis readily differentiated between the nuclear morphologies of non-transfected cells and those induced by CENP-V and the two mutants. The phenotypes induced by the two mutants were most closely related, whereas those of the non-transfected and CENP-V-expressing cells were readily distinguished. Close examination of the dendrogram reveals some of the heterogeneity of the raw data (e.g. mutant C174A nucleus A11 had a condensed phenotype similar to that seen with wild-type CENP-V). Overall, this analysis clearly reveals that mutation of the putative catalytic site of CENP-V causes a marked alteration in its ability to reorganize the nuclear chromatin in transfected cells. Depletion of CENP-V by RNAi affects the distribution of pericentromeric heterochromatin in interphase nuclei CENP-V overexpression or knockdown by RNAi cause either a hypercondensation of pericentromeric heterochromatin or expansion of the centromere of mitotic chromosomes, respectively. As chromatin states are regulated at least in part by post-translational modifications of the core histones, we therefore asked whether alteration of CENP-V levels has an effect on the levels or distribution of certain key modifications. Alteration of CENP-V levels had no detectable effect on overall levels of three key histone modifications. H3K9me3 (a marker for heterochromatin), H3K4me2 (a marker for ‘open' and centromeric chromatin) and H3K27me3 (a marker for silenced genes regulated by EZH2) levels did not change following knockdown of CENP-V by siRNA (Figures 3A
Depletion of CENP-V did, however, cause a significant alteration in the nuclear distribution of H3K9me3. Control HeLa cell nuclei exhibited dense patches stained with antibody specific for H3K9me3 that were distributed throughout the nuclear interior and adjacent to the inner nuclear membrane and periphery of the nucleolus (Figure 7A and A′ Discussion CENP-V is a putative enzyme and novel centromeric protein identified in a proteomic screen of mitotic chromosome scaffolds (Gassmann et al, 2005) that has the ability to induce hypercondensation of pericentromeric chromatin in interphase nuclei and is required for the normal morphology of the primary constriction of mitotic chromosomes. CENP-V is required for the stability and targeting of the CPC to centromeres and when it is depleted by RNAi, cells exhibit classical CPC phenotypes including failure to complete chromosome bi-orientation and failure to complete cytokinesis. CENP-V levels are critical for cell viability, and either lowering or increasing levels of the protein leads to cell death. CENP-V RNAi also induces dramatic changes in cell shape prior to death, so the protein may have other functions in addition to its role(s) at centromeres. The role of CENP-V in the architecture of the primary constriction of mitotic chromosomes may involve its ability to induce chromatin condensation. We showed previously that CENP-V overexpression causes hypercondensation of chromatin in interphase nuclei, and that the condensed chromatin domains are proximal to the kinetochore (Gassmann et al, 2005). Here, we confirmed that the condensed domains largely colocalize with H3K9me3, a marker for heterochromatin. This suggests that CENP-V overexpression can promote the condensation of interphase pericentromeric heterochromatin. In a recent study examining the spring-like behaviour of centromeres, it was shown that altering chromatin higher order structure by lowering levels of a core histone causes an increase in the ‘rest length' of the spring (i.e. the distance between sister kinetochores when the centromere is not under load) (Bouck and Bloom, 2007). In previous work from our laboratory, we showed that although the condensin complex is required for complete compaction of the arms of mitotic chromosomes (Vagnarelli et al, 2006), it is not required to set the rest length of the centromere spring (Hudson et al, 2003). Here, we find that depletion of CENP-V also causes an increase in the centromeric rest length by a factor of ~1.7, an effect greater than that seen following depletion of histone H4 in yeast (Bouck and Bloom, 2007). CENP-V depletion has no apparent effect on the distribution of condensin, and furthermore, when CENP-V-depleted cells enter anaphase, they do not exhibit the dramatic loss of compact architecture seen in condensin-depleted cells (Hudson et al, 2003; Vagnarelli et al, 2006). One important functional consequence of the alteration of the primary constriction caused by CENP-V depletion is destabilization and delocalization of the CPC. This CPC delocalization is reminiscent of the phenotype seen following depletion of the essential cohesin subunit Rad21/Scc1 and the key mitotic regulator Bub1 from chicken centromeres (Sonoda et al, 2001; Kitajima et al, 2005; Boyarchuk et al, 2007) and is accompanied by partial delocalization of the cohesin regulator Sgo1. The CPC is required for stable localization of shugoshins such as MEI-S332 to centromeres (Resnick et al, 2006) and indeed heterochromatin itself also has an important role in promoting cohesin binding (Bernard et al, 2001; Nonaka et al, 2002). Interestingly, Bub1 and CENP-50 depletion has been reported to cause an increase in the spacing between sister kinetochores, although this was interpreted as a decrease in cohesion/adhesion rather than an increase in centromeric ‘rest length' (Kitajima et al, 2005; Minoshima et al, 2005). The CPC can regulate the chromosomal association of chromatin remodelling complexes in Xenopus (MacCallum et al, 2002) and can also interact with histone and non-histone proteins in pericentromeric chromatin (Rangasamy et al, 2003). Whether CENP-V exerts its effect on centromeric architecture indirectly through effects on the chromosomal passenger proteins or more directly by modulating the formation or organization of pericentromeric heterochromatin remains to be determined. Importantly, CENP-V depletion causes no detectable effect on sister chromatid cohesion. Instead, the dominant phenotypes seen after CENP-V depletion resemble those observed following disruption of the CPC. Chromosomes are perturbed in their ability to undergo normal bi-orientation, and those cells that do enter anaphase and undergo mitotic exit typically fail to complete cytokinesis. Where the CENP-V phenotype differs, however, is in the aftermath of this mitotic failure. Typically, interference with CPC function results in the accumulation of multinucleated cells and eventual cell death by apoptosis. In the case of CENP-V depletion, the consequences are more severe—the mitotic failures are followed by apoptotic death with little or no delay. The reason for this more severe phenotype is not known, but one possibility is that CENP-V also has other essential functions during interphase. The cellular distribution of CENP-V is consistent with its apparent role(s) both as an architectural factor in the primary constriction and as a factor influencing CPC stability and function. The distribution of endogenous CENP-V in mitosis is most similar to that of the kinesin CENP-E, although the two proteins do not exactly colocalize in the kinetochore. Both proteins are found in the outer kinetochore (with CENP-V showing most overlap with Hec1), but then transfer to the central spindle and mid-body after anaphase onset. How CENP-V influences centromere architecture from this position is not known. However, it is worth pointing out that PLK1, which also influences the architecture of the inner centromere, has a similar localization in the outer kinetochore (Nishino et al, 2006). The suggestion that CENP-V might be a factor preferentially involved in the architecture of centromeric chromatin is particularly interesting, as examination of its sequence suggests that the protein may be an enzyme functionally related to GFA of P. denitrificans. A structural model for CENP-V based on a target-to-template alignment shared many similarities with GFA-Pn, raising the possibility that CENP-V could have a similar biochemical function. Importantly, two catalytic mutants of CENP-V designed based on this predicted structure were shown by a novel pattern recognition analysis algorithm to be unable to induce chromatin hypercondensation in a pattern similar to the wild-type protein when overexpressed in HeLa cells. Consideration of the function of GFA-Pn suggests a possible mechanism for CENP-V action in chromatin. Pericentromeric chromatin is characterized by having high concentrations of H3K9me3 and H4K20me3 (Bannister et al, 2001; Peters et al, 2003; Rice et al, 2003; Schotta et al, 2004), whereas transcribed bodies of genes are enriched in H3K4me3 (Santos-Rosa et al, 2002). In recent years, the ‘histone code' hypothesis has attracted interest in part because of the discovery of the enzymes that catalyse these methylation reactions. Histone methylation was originally considered a static modification, but this changed with the identification of histone demethylases. The first of these, LSD1, specifically demethylates lysine 4 of histone H3 (Shi et al, 2004), releasing formaldehyde as a by-product. Formaldehyde is toxic and is usually metabolized by cells through a pathway that involves glutathione. Although this reaction occurs spontaneously, bacteria use enzymes such as GFA-Pn to catalyse the formation of S-hydroxymethylglutathione. This suggests that CENP-V could be an enzyme that scavenges the formaldehyde produced in histone demethylation reactions. If removal of formaldehyde helped to drive the forward reaction, then depending on the histone demethylation events involved, this could be one mechanism by which CENP-V could promote chromatin compaction. Overexpression of wild-type CENP-V or depletion of the protein by siRNA did not affect global levels of H3K4me2, H3K27me3, or global levels and localization of H3K9me3 (Figures 3A CENP-V has provided an intriguing link between the CPC, the primary constriction of mitotic chromosomes and pericentromeric heterochromatin. Unfortunately, very preliminary attempts to observe a catalytic effect of CENP-V on formaldehyde produced during histone demethylation assays in vitro were negative (R Klose, personal communication). However, this initial effort was hampered by our lack of information about the cofactors and auxiliary subunits, if any, required for CENP-V activity. Determining the detailed mechanism of CENP-V action remains an exciting challenge for future studies. Materials and methods Oligonucleotides A 21-mer oligonucleotide end labelled with Alexa555 fluorophore (GCAGCAUUUGCAAGAAGAAdTdT) covering bases 519–539 downstream of the translational start codon of human CENP-V cDNA (Uniprot/SWISSPROT Q7Z7K6) was selected as the targeting sequence among four oligonucleotides generated according to ‘HP OnGuard siRNA Design' from Qiagen. This sequence is unique to human CENP-V. A 21-mer oligonucleotide end labelled with Alexa555 fluorophore (CGUACGCGGAAUACUUCGAdTdT) with no significant homology to any known human mRNA in the databases was used as a control (Elbashir et al, 2001). The double-stranded RNA oligomers (siRNA) were supplied as annealed duplexes (Qiagen). Cell culture and RNAi HeLa cells in exponential growth were seeded onto polylysine-coated glass coverslips and grown overnight in RPMI/10% FBS (Gibco-BRL), 5% CO2 and at 37°C. RNAi was performed as previously described (Elbashir et al, 2001). A single pulse of 60 pmol of siRNA was administered to the cells at 30–40% confluence by transfection with OligoFectamine (Invitrogen) in complete medium without antibiotics. Cells were maintained in this medium for the duration of the experiment and assayed for CENP-V silencing, for CPC localization and cellular levels and for heterochromatin marker levels by indirect immunofluorescence and immunoblotting. Unfortunately, we were unable to perform siRNA rescue experiments to confirm the specificity of the RNAi phenotype, as expression of wild-type or mutant CENP-V was highly toxic, killing transfected HeLa cells within ~48–60 h. Similar toxicity has been seen with the expression of the centromere-associated helicase PICH (Baumann et al, 2007). However, we could demonstrate that the siRNA causes a specific depletion of CENP-V, and the resulting centromeric phenotypes are entirely consistent with the localization of the endogenous protein. Indirect immunofluorescence microscopy and immunoblotting HeLa cells grown on polylysine-coated coverslips were fixed for 5 min with 4% (v/v) paraformaldehyde (Electron Microscopy Services) in CB buffer (137 mM NaCl, 5 mM KCl, 1.1 mM Na2HPO4, 0.4 mM KH2PO4, 2 mM MgCl2, 2 mM EGTA, 5.5 mM glucose, 5 mM PIPES, pH 6.1). After permeabilization with 0.15 % (v/v) Triton X-100 in CB, coverslips were blocked with 1% (v/v) BSA in CB buffer. Cells were probed with antibodies against H3(S10)p (1/200, mouse; Cell Signaling). Alternatively, HeLa cells grown on polylysine-coated coverslips were fixed with cold MeOH at −20°C and blocked with 0.5% (v/v) BSA, 0.1% Tween 20 in PBS. Later, cells were probed with antibodies against CENP-V (Ra4552, 1:100, rabbit), Hec1 (1:500, mouse; Abcam), α-tubulin (B512, 1:2000, mouse; Sigma), CENP-B (2D7, 1:20, monoclonal; William C Earnshaw), CENP-E (1:200, monoclonal; William C Earnshaw), CENP-A (1:300; Hiroshi Masumodo, Nagoya University, Japan), H3K9me3 (1:2000, rabbit; Upstate); INCENP (1:50, mouse; Upstate), Aurora B (AIM-11:500, monoclonal; BD Transduction Laboratories), Sgo1 (1:1000, rabbit; Abcam), EB1 (1:100, monoclonal; BD Transduction Laboratories) and ACA were used to stain the centromeres (1/300, human). To check CENP-V localization in the absence of microtubules, HeLa JW cells were treated with colcemid (100 ng/ml) for 2 h prior to MeOH fixation as described above. Chromosome spreads were made by hypotonically swelling colcemid-treated cells with 75 mM KCl prior to fixation. Fixation was done with cold methanol. Washes with 0.1% (v/v) TEEN (1 mM triethanolamine HCl pH 8.5, 0.2 mM Na EDTA, 25 mM NaCl), 0.1% (v/v) BSA and 0.1% (v/v) Triton X-100 followed the fixation protocol. Later, cells were incubated with primary antibodies against Sgo1, ACA, SMC2 (1:200, rabbit; William C Earnshaw), Aurora B and INCENP, diluted in 0.1% (v/v) TEEN, 0.1% (v/v) BSA and 0.1% (v/v) Triton X-100. Coverslips were washed with KB− (10 mM Tris HCl pH 7.7, 0.15 M NaCl, 1% (v/v) BSA). In all cases, we used secondary antibodies coupled to FITC, Texas red, rhodamine or Cy5, and DNA was stained with DAPI (Sigma). Total extracts of HeLa cells treated with control or CENP-V-specific oligonucleotides, HeLa cells transiently transfected with the constructs: CENP-V–GFP, C174A–GFP or CC174/177AA, and HeLa cells stably expressing CENP-V–GFP–TrAP were harvested in Laemmli buffer containing β-mercaptoethanol. The samples were run in a SDS–PAGE gel and blotted onto nitrocellulose membranes (Amersham). The membranes were blocked with 5% skimmed milk in PBS/0.05% Tween 20 and incubated later with either an anti-CENP-V antibody (Ra4553 affinity purified, diluted 1/250) in 3% milk/PBS/0.1% Tween 20 with Aurora B, INCENP, α-tubulin or with anti-H3K9me3, H4K9me2 and H3K27me3, according to the manufacturer's instructions. The membranes were incubated with anti-rabbit horseradish peroxidase-linked secondary antibody (diluted 1/10 000; Amersham) in 1% milk/PBS/0.05% Tween 20 and results were visualized using the enhanced chemiluminescence protocol (Amersham). Time-lapse imaging Cells were seeded onto coverslips, and treated with siRNA or transfected with CENP-V–GFP construct (see Supplementary data). For the RNAi experiment, the coverslip was transferred to a Rose Chamber 24 h after transfection with the siRNA oligonucleotide. DIC and FITC 3D image datasets were collected every minute using an inverted Nikon Eclipse TE2000-E fluorescence microscope heated to 37°C and equipped with × 40 and × 60 objectives. At least 30 cells were followed for 48 h in each experiment. For determining the fate of cells overexpressing CENP-V–GFP, the coverslip was transferred to a Rose Chamber, 24 h after transfection. DIC 3D image datasets were collected every 5 min using the Nikon Eclipse TE2000-E microscope heated to 37°C and equipped with a × 40 objective. At least 50 mitotic and interphase transfected cells as well as non-transfected cells were followed for 48 h. Bioinformatic and pattern recognition analysis The CENP-V structural model was constructed based on a target-to-template sequence alignment of CENP-V and GFA-Pn. The automated PFAM alignment (pfam04828) was manually adjusted taking into account the known 3D structure of GFA-Pn (PDB:1xa8) and coincidences of predicted (CENP-V) and known (GFA-Pn) secondary structure (Figure 1 The 3D structure and secondary structure of GFA-Pn (PDB: 1xa8) were also used for the modelling of the CENP-V structure. The atomic coordinates of the structural model were generated using the software SYBYL (Tripos™: www.tripos.com, Tripos Inc.). The difference between the overexpression phenotypes of CENP-V–GFP and the mutants C174A–GFP and CC172/177AA–GFP was quantified using WND-CHARM (Orlov et al, 2006). WND-CHARM is a general purpose pattern analysis and classification tool for images. Given a set of training images segregated into classes, WND-CHARM reports similarity statistics between images or classifies unknown images into one of the defined classes. Four classes were defined for WND-CHARM (A, B, GFP and NT) corresponding to the two mutants, CENP-V–GFP and untransfected cells. Twenty maximum-intensity projected images were used to train each class. For each input image, WND-CHARM reports a set of marginal probabilities corresponding to the image's similarity to each of the classes used in training. The four values reported for each image in this case were used as coordinates in a ‘marginal probability space' to compute similarities between images. The set of pairwise distances between all images were used as inputs to the ‘fitch' program from the PHYLIP package to compute a dendrogram. The dendrogram was rendered by ‘drawtree' from PHYLIP, and was further colourized based on each image's class membership and relative distance to other images in the dendrogram. Supplementary data Click here to view.(43K, doc) Supplementary Movie 1 Click here to view.(4.4M, mov) Supplementary Movie 2 Click here to view.(4.5M, mov) Supplementary Movie 3 Click here to view.(2.4M, mov) Supplementary Movie 4 Click here to view.(4.0M, mov) Supplementary Movie 5 Click here to view.(7.8M, mov) Supplementary Movie 6 Click here to view.(1.1M, mov) Supplementary Movie 7 Click here to view.(8.0M, mov) Supplementary Movie 8 Click here to view.(7.9M, mov) Supplementary Movie 9 Click here to view.(6.2M, mov) Supplementary Figures Click here to view.(6.2M, pdf) Acknowledgments We thank R Klose (Oxford, UK) for performing histone de-methylase assays, H Masumoto (Nagoya, Japan) for anti-CENP-A. In Edinburgh, we thank D Kelly for help with image analysis, P Vagnarelli for advice and all members of the Earnshaw laboratory for comments on the paper. AMB Tadeu is a PhD student at the Programa Doutoral em Biologia Experimental e Biomedicina of the Universidade de Coimbra supported by a PhD fellowship from FCT-Fundação para a Ciência e Tecnologia of Portugal. The laboratory of WC Earnshaw is funded by the Wellcome Trust, of which he is a Principal Research Fellow. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Dev Cell. 2004 Nov; 7(5):637-51.
[Dev Cell. 2004]Nat Rev Mol Cell Biol. 2007 May; 8(5):379-93.
[Nat Rev Mol Cell Biol. 2007]J Cell Sci. 2004 Nov 1; 117(Pt 23):5461-77.
[J Cell Sci. 2004]Trends Cell Biol. 2005 Nov; 15(11):589-98.
[Trends Cell Biol. 2005]Nat Rev Mol Cell Biol. 2008 Jan; 9(1):33-46.
[Nat Rev Mol Cell Biol. 2008]Nature. 2000 Jan 6; 403(6765):41-5.
[Nature. 2000]Trends Cell Biol. 2001 Jun; 11(6):266-73.
[Trends Cell Biol. 2001]Curr Opin Genet Dev. 2006 Apr; 16(2):125-36.
[Curr Opin Genet Dev. 2006]Cell. 2007 Feb 23; 128(4):693-705.
[Cell. 2007]Nature. 2001 Mar 1; 410(6824):120-4.
[Nature. 2001]Nat Cell Biol. 2002 Jan; 4(1):89-93.
[Nat Cell Biol. 2002]Trends Biochem Sci. 2005 Apr; 30(4):172-5.
[Trends Biochem Sci. 2005]Nat Struct Mol Biol. 2004 Nov; 11(11):1076-83.
[Nat Struct Mol Biol. 2004]Annu Rev Genomics Hum Genet. 2006; 7():301-13.
[Annu Rev Genomics Hum Genet. 2006]Chromosoma. 2004 Nov; 113(5):211-22.
[Chromosoma. 2004]J Cell Biol. 2006 Jun 19; 173(6):833-7.
[J Cell Biol. 2006]Nat Rev Mol Cell Biol. 2007 Oct; 8(10):798-812.
[Nat Rev Mol Cell Biol. 2007]J Cell Sci. 1991 Apr; 98 ( Pt 4)():443-61.
[J Cell Sci. 1991]J Cell Biol. 2007 Mar 26; 176(7):919-28.
[J Cell Biol. 2007]Chromosoma. 2005 Feb; 113(7):385-97.
[Chromosoma. 2005]J Cell Biol. 2002 Sep 2; 158(5):915-27.
[J Cell Biol. 2002]J Mol Biol. 1990 Oct 5; 215(3):403-10.
[J Mol Biol. 1990]Proteins. 1997 Jul; 28(3):405-20.
[Proteins. 1997]J Biol Chem. 2005 Jan 28; 280(4):2826-30.
[J Biol Chem. 2005]J Biol Chem. 2005 Jan 28; 280(4):2826-30.
[J Biol Chem. 2005]EMBO J. 1991 May; 10(5):1245-54.
[EMBO J. 1991]Dev Cell. 2003 Aug; 5(2):323-36.
[Dev Cell. 2003]Dev Cell. 2006 Jul; 11(1):57-68.
[Dev Cell. 2006]Dev Cell. 2006 Nov; 11(5):741-50.
[Dev Cell. 2006]J Cell Biol. 2007 May 7; 177(3):413-24.
[J Cell Biol. 2007]Genes Dev. 2007 Feb 15; 21(4):420-35.
[Genes Dev. 2007]J Cell Sci. 2003 Jul 15; 116(Pt 14):2987-98.
[J Cell Sci. 2003]Cell Cycle. 2003 Nov-Dec; 2(6):507-10.
[Cell Cycle. 2003]J Cell Biol. 2004 Jul 19; 166(2):179-91.
[J Cell Biol. 2004]J Cell Sci. 2003 Jul 15; 116(Pt 14):2987-98.
[J Cell Sci. 2003]Cell Cycle. 2003 Nov-Dec; 2(6):507-10.
[Cell Cycle. 2003]J Cell Biol. 2004 Jul 19; 166(2):179-91.
[J Cell Biol. 2004]Chromosoma. 2005 Feb; 113(7):385-97.
[Chromosoma. 2005]Chromosoma. 2005 Feb; 113(7):385-97.
[Chromosoma. 2005]Chromosoma. 2005 Feb; 113(7):385-97.
[Chromosoma. 2005]Curr Biol. 2007 May 1; 17(9):741-8.
[Curr Biol. 2007]Nat Cell Biol. 2006 Oct; 8(10):1133-42.
[Nat Cell Biol. 2006]Dev Cell. 2003 Aug; 5(2):323-36.
[Dev Cell. 2003]Dev Cell. 2001 Dec; 1(6):759-70.
[Dev Cell. 2001]Curr Biol. 2005 Feb 22; 15(4):353-9.
[Curr Biol. 2005]J Cell Biol. 2007 Mar 26; 176(7):919-28.
[J Cell Biol. 2007]Dev Cell. 2006 Jul; 11(1):57-68.
[Dev Cell. 2006]Nat Cell Biol. 2002 Jan; 4(1):89-93.
[Nat Cell Biol. 2002]Mol Biol Cell. 2002 Jan; 13(1):25-39.
[Mol Biol Cell. 2002]EMBO J. 2003 Apr 1; 22(7):1599-607.
[EMBO J. 2003]Curr Biol. 2006 Jul 25; 16(14):1414-21.
[Curr Biol. 2006]Nature. 2001 Mar 1; 410(6824):120-4.
[Nature. 2001]Mol Cell. 2003 Dec; 12(6):1577-89.
[Mol Cell. 2003]Mol Cell. 2003 Dec; 12(6):1591-8.
[Mol Cell. 2003]Genes Dev. 2004 Jun 1; 18(11):1251-62.
[Genes Dev. 2004]Nature. 2002 Sep 26; 419(6905):407-11.
[Nature. 2002]Nature. 2001 May 24; 411(6836):494-8.
[Nature. 2001]Nature. 2001 May 24; 411(6836):494-8.
[Nature. 2001]Cell. 2007 Jan 12; 128(1):101-14.
[Cell. 2007]J Mol Biol. 2000 Sep 8; 302(1):205-17.
[J Mol Biol. 2000]Bioinformatics. 2004 Feb 12; 20(3):426-7.
[Bioinformatics. 2004]